"Corneal blindness is one of the leading causes of vision loss, affecting about 10 million people worldwide each year," says ...
Obtained ex-US Regulatory Clearance for DT-818, a Potentially Best-in-Disease Treatment for Myotonic Dystrophy Type-1 (DM1) Trials of DT-216P2 in Friedreich Ataxia (FA) and DT-168 in Fuchs Endothelial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback